Public health communications professionals from around the country honored a joint effort by the University of Washington and Public Health – Seattle & King County to prepare public health workers and people in related fields to get emergency information out to the general public quickly and effectively.
An effective contraceptive for men would make a welcome new family planning option. Researchers report that male rats given an experimental new treatment became infertile within four weeks, and that the effect was reversible. The accomplishment might lead researchers to a safe and effective contraceptive for men.
This week’s New England Journal of Medicine reported that annual chest computed tomography (CT) scans on those at risk for lung cancer can detect it earlier, at a more treatable stage. In the study, more than 31,000 people in the United States and overseas underwent spiral CT scans of their chests at the beginning and again in seven to 18 months unless something was detected on the first scan.
Bringing hope to hundreds of children in one of the countries hardest hit by HIV/AIDS, the Abbott Fund, Baylor College of Medicine and the Government of Malawi have joined forces to build the country’s first pediatric HIV clinic. The First Lady of Malawi, Madame Ethel Zvauya Mutharika and other dignitaries at Kamuzu Central Hospital officially opened the new clinic today in the city of Lilongwe.
Clinical data demonstrated continued efficacy and tolerability of LEVITRA in men with ED and high blood pressure, diabetes and/or dyslipidemia, including high cholesterol. LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated medical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. These data were presented today at the Sexual Medicine Society of North America (SMSNA) Fall meeting and published in the November issue of the International Journal of Clinical Practice.
A team of researchers has used computer simulations to explain how cells adhere so firmly to blood vessel walls.
Physicists from the University of Pennsylvania tackle the fundamental question of how DNA can seemingly violate physics. That is, if DNA is such a rigid molecule, how can it bend and coil without requiring large amounts of force? They used a technique called atomic force microscopy to determine that DNA is much more flexible than previously believed when examined over nano-sized lengths
A protein with the ironic name “Srcasm” can counteract the effects of tumor-promoting molecules in skin cells, according to new research by investigators at the University of Pennsylvania School of Medicine. Using animal models, the researchers discovered that Srcasm acts like a brake in epithelial cells, preventing uncontrolled cell growth caused by a family of proteins called Src kinases. This finding, published online in the Journal of Biological Chemistry, suggests a target for future gene therapy to treat skin, head, neck, colon, and breast cancers.
How well an individual’s immune system controls HIV during the earliest phases of infection appears to depend on both the specific versions of key immune-system molecules called HLA Class I that have been inherited, as well as on the fragments of viral protein those molecules display to the T lymphocytes that usually destroy infected cells. In a report in the November issue of PLOS Medicine, researchers from the Partners AIDS Research Center at Massachusetts General Hospital (PARC/MGH) report that specific HLA Class I/HIV viral fragment combinations are associated with a more powerful antiviral response, findings that may help develop vaccines against HIV.
New Saint Louis University research that outlines the top 10 factors that encourage people to be physically active is a blueprint to design healthier communities.